SHARE-BASED COMPENSATION - Stock Option Activity (Details) - USD ($)
|
12 Months Ended |
Dec. 31, 2019 |
Dec. 31, 2018 |
| Private Innovate 2015 Stock Incentive Plan |
|
|
| Number of Shares |
|
|
| Outstanding, beginning balance (in shares) |
6,340,871
|
|
| Options granted (in shares) |
0
|
0
|
| Options forfeited (in shares) |
(177,047)
|
|
| Options exercised (in shares) |
(100,079)
|
|
| Outstanding, ending balance (in shares) |
6,063,745
|
6,340,871
|
| Options exercisable (in shares) |
5,672,827
|
|
| Options vested and expected to vest (in shares) |
6,052,384
|
|
| Weighted-Average Exercise Price |
|
|
| Outstanding at beginning of period (in dollars per share) |
$ 1.53
|
|
| Options forfeited (in dollars per share) |
2.08
|
|
| Options exercised (in dollars per share) |
0.30
|
|
| Outstanding at end of period (in dollars per share) |
1.53
|
$ 1.53
|
| Exercisable at beginning of period (in dollars per share) |
1.49
|
|
| Vested and expected to vest (in dollars per share) |
$ 1.53
|
|
| Aggregate Intrinsic Value |
|
|
| Outstanding at December 31, 2018 |
$ (496,275)
|
$ (4,978,205)
|
| Exercisable at December 31, 2019 |
496,275
|
|
| Vested and expected to vest at December 31, 2019 |
$ 496,275
|
|
| Weighted-Average Remaining Contractual Life (in years) |
|
|
| Outstanding at December 31, 2018 |
5 years 4 months 24 days
|
7 years 8 months 12 days
|
| Exercisable at December 31, 2019 |
5 years 3 months 18 days
|
|
| Vested and expected to vest at December 31, 2019 |
5 years 4 months 24 days
|
|
| For possible future issuance under the Omnibus Plan |
|
|
| Number of Shares |
|
|
| Outstanding, beginning balance (in shares) |
776,131
|
|
| Options granted (in shares) |
2,366,344
|
|
| Options forfeited (in shares) |
(424,605)
|
|
| Options exercised (in shares) |
0
|
|
| Outstanding, ending balance (in shares) |
2,717,870
|
776,131
|
| Options exercisable (in shares) |
1,444,501
|
|
| Options vested and expected to vest (in shares) |
2,619,282
|
|
| Weighted-Average Exercise Price |
|
|
| Outstanding at beginning of period (in dollars per share) |
$ 5.79
|
|
| Options granted (in dollars per share) |
1.33
|
|
| Options forfeited (in dollars per share) |
6.02
|
|
| Options exercised (in dollars per share) |
0.00
|
|
| Outstanding at end of period (in dollars per share) |
1.87
|
$ 5.79
|
| Exercisable at beginning of period (in dollars per share) |
2.05
|
|
| Vested and expected to vest (in dollars per share) |
$ 1.86
|
|
| Aggregate Intrinsic Value |
|
|
| Outstanding at December 31, 2018 |
$ 0
|
$ 0
|
| Exercisable at December 31, 2019 |
0
|
|
| Vested and expected to vest at December 31, 2019 |
$ 0
|
|
| Weighted-Average Remaining Contractual Life (in years) |
|
|
| Outstanding at December 31, 2018 |
9 years 4 months 24 days
|
7 years 4 months 24 days
|
| Exercisable at December 31, 2019 |
9 years 3 months 18 days
|
|
| Vested and expected to vest at December 31, 2019 |
9 years 4 months 24 days
|
|